• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-200b/200a/429 簇可预防转移并诱导 Claudin-Low 型小鼠乳腺肿瘤细胞系休眠。

The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell line.

机构信息

Department of Biomedical Science, Ontario Veterinary College, University of Guelph, 50 Stone Road East, Guelph, Ontario, Canada N1G2W1.

出版信息

Exp Cell Res. 2018 Aug 1;369(1):17-26. doi: 10.1016/j.yexcr.2018.04.024. Epub 2018 Apr 25.

DOI:10.1016/j.yexcr.2018.04.024
PMID:29702103
Abstract

The miR-200 family of microRNAs consisting of miR-141, miR-200a, miR-200b, miR-200c and miR-429 are emerging as important regulators of breast cancer progression. This family of microRNAs maintain mammary epithelial identity and downregulation of miR-200 expression has been associated with epithelial-to-mesenchymal transition in mammary tumors. Therefore, re-expression of one or more miR-200 family members in mammary tumor cells with mesenchymal characteristics may restore an epithelial phenotype including growth and metastasis suppression. To test this hypothesis, the miR-200b/200a/429 cluster was re-expressed in a murine claudin-low cell line, RJ423. Re-expression of the miR-200b/200a/429 cluster in RJ423 cells significantly suppressed the expression of Vim, Snai1, Twist1, Twist2 and Zeb1, reverted RJ423 cells to a more epithelial morphology and significantly inhibited proliferation in vitro. Moreover, the miR-200b/200a/429 cluster prevented lung metastasis in an experimental metastasis model and although tumor initiation was not prevented, re-expression of the miR-200b/200a/429 cluster induced a dormancy-like state where mammary tumors failed to grow beyond ~150 mm or grew extremely slowly following intra-mammary injection. These dormant tumors contained elevated levels of collagen and were highly vascularized. Therefore, re-expression of the miR-200b/200a/429 cluster in the claudin-low mammary tumor cell line, RJ423, is sufficient to alter cell morphology, impair metastasis and induce tumor dormancy.

摘要

miR-200 家族由 miR-141、miR-200a、miR-200b、miR-200c 和 miR-429 组成,它们作为乳腺癌进展的重要调节因子而崭露头角。这个 miRNA 家族维持着乳腺上皮细胞的特性,miR-200 表达的下调与乳腺肿瘤中的上皮间质转化有关。因此,在具有间质特征的乳腺肿瘤细胞中重新表达一个或多个 miR-200 家族成员可能会恢复上皮表型,包括生长和转移抑制。为了验证这一假说,我们在小鼠 Claudin-low 细胞系 RJ423 中重新表达了 miR-200b/200a/429 簇。在 RJ423 细胞中重新表达 miR-200b/200a/429 簇显著抑制了 Vim、Snai1、Twist1、Twist2 和 Zeb1 的表达,使 RJ423 细胞的形态更具上皮特征,并显著抑制了体外增殖。此外,miR-200b/200a/429 簇在实验性转移模型中阻止了肺转移,尽管肿瘤起始没有被阻止,但 miR-200b/200a/429 簇的重新表达诱导了一种休眠样状态,其中乳腺肿瘤在乳腺内注射后无法生长超过 150mm 或生长极其缓慢。这些休眠肿瘤中胶原水平升高,血管化程度高。因此,在 Claudin-low 乳腺肿瘤细胞系 RJ423 中重新表达 miR-200b/200a/429 簇足以改变细胞形态、损害转移并诱导肿瘤休眠。

相似文献

1
The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell line.miR-200b/200a/429 簇可预防转移并诱导 Claudin-Low 型小鼠乳腺肿瘤细胞系休眠。
Exp Cell Res. 2018 Aug 1;369(1):17-26. doi: 10.1016/j.yexcr.2018.04.024. Epub 2018 Apr 25.
2
Re-expression of miR-200s in claudin-low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes.在claudin低表达的乳腺肿瘤细胞中重新表达miR-200s可改变细胞形态,并可能通过调节其他miRNA和SUZ12调控的基因来降低细胞增殖和侵袭能力。
Cancer Cell Int. 2021 Feb 4;21(1):89. doi: 10.1186/s12935-021-01784-4.
3
Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.miR-141/200c簇的过表达通过分泌VEGF-A激活FAK和PI3K/AKT信号通路,从而促进三阴性乳腺癌细胞的迁移和侵袭能力。
BMC Cancer. 2016 Aug 2;16:570. doi: 10.1186/s12885-016-2620-7.
4
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.血清miR-200a、miR-200b和miR-200c作为上皮性卵巢癌候选生物标志物的表达及其与临床病理特征的关联。
Clin Transl Oncol. 2015 Oct;17(10):779-87. doi: 10.1007/s12094-015-1303-1. Epub 2015 Jun 11.
5
MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.miR-200 可通过非 ZEB1 依赖但肌球蛋白依赖的途径抑制乳腺癌转移。
Oncogene. 2014 Jul 31;33(31):4077-88. doi: 10.1038/onc.2013.370. Epub 2013 Sep 16.
6
Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.下调的 microRNA-200a 通过靶向胃腺癌中的 E-钙黏蛋白抑制剂 ZEB1/ZEB2,通过 wnt/β-连环蛋白通路促进 EMT 和肿瘤生长。
Oncol Rep. 2013 Apr;29(4):1579-87. doi: 10.3892/or.2013.2267. Epub 2013 Jan 31.
7
Transgenic overexpression of the miR-200b/200a/429 cluster inhibits mammary tumor initiation.miR-200b/200a/429簇的转基因过表达抑制乳腺肿瘤起始。
Transl Oncol. 2021 Dec;14(12):101228. doi: 10.1016/j.tranon.2021.101228. Epub 2021 Sep 22.
8
Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.miR-200c在claudin低表达型乳腺癌中的表达改变了干细胞功能,增强了化学敏感性并降低了转移潜能。
Oncogene. 2015 Dec 3;34(49):5997-6006. doi: 10.1038/onc.2015.48. Epub 2015 Mar 9.
9
MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis.微小RNA-200b/200c/429亚家族负向调控Rho/ROCK信号通路以抑制肝细胞癌转移。
Oncotarget. 2015 May 30;6(15):13658-70. doi: 10.18632/oncotarget.3700.
10
Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells.miR-200c的重新表达可抑制小鼠claudin低表达乳腺肿瘤细胞的增殖、集落形成及体内肿瘤生长。
Oncotarget. 2017 Apr 4;8(14):23727-23749. doi: 10.18632/oncotarget.15829.

引用本文的文献

1
Reduced JAG1 Expression Through miR-200 Overexpression or Crispr-Cas Mediated Knockout Impairs TNBC Growth and Metastasis.通过miR-200过表达或Crispr-Cas介导的敲除降低JAG1表达会损害三阴性乳腺癌的生长和转移。
Mol Carcinog. 2025 Aug;64(8):1392-1407. doi: 10.1002/mc.23937. Epub 2025 Jun 11.
2
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.肿瘤休眠与复发:理解癌症复发的分子机制
Mil Med Res. 2025 Feb 11;12(1):7. doi: 10.1186/s40779-025-00595-2.
3
Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy.
表观遗传学前沿:miRNAs、长非编码 RNA 和纳米材料正在开创癌症治疗的先河。
Epigenetics Chromatin. 2024 Oct 16;17(1):31. doi: 10.1186/s13072-024-00554-6.
4
Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells.miR-200s 的过表达抑制了小鼠卵巢癌细胞的增殖和侵袭,同时增加了细胞凋亡。
PLoS One. 2024 Jul 19;19(7):e0307178. doi: 10.1371/journal.pone.0307178. eCollection 2024.
5
Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis.吴茱萸碱通过抑制谷胱甘肽过氧化物酶 4 和诱导铁死亡发挥抗膀胱癌活性。
Int J Mol Sci. 2023 Mar 23;24(7):6021. doi: 10.3390/ijms24076021.
6
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment.具有多个免疫检查点靶点的微小RNA,作为乳腺癌治疗中免疫检查点抑制剂的潜在增敏剂
Cancers (Basel). 2023 Jan 29;15(3):824. doi: 10.3390/cancers15030824.
7
Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification.通过利用miRNA-200c控制的II期解毒来对抗耐药性
Cancers (Basel). 2022 Nov 11;14(22):5554. doi: 10.3390/cancers14225554.
8
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics.miR-200 家族作为抗癌治疗靶点的潜力。
Int J Mol Sci. 2022 May 24;23(11):5881. doi: 10.3390/ijms23115881.
9
Elevated Expression of miR-200c/141 in MDA-MB-231 Cells Suppresses Levels and Impairs Breast Cancer Growth and Metastasis In Vivo.miR-200c/141 在 MDA-MB-231 细胞中的高表达抑制了 水平,并损害了体内乳腺癌的生长和转移。
Genes (Basel). 2022 Apr 14;13(4):691. doi: 10.3390/genes13040691.
10
Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.癌症免疫编辑:实体瘤中的消除、平衡和免疫逃逸。
Exp Suppl. 2022;113:1-57. doi: 10.1007/978-3-030-91311-3_1.